Success Stories: A Senior Application Engineer in the field of Biotechnology Achieves NIW and EB1B case approvals with the Help of Our Assistance.

Posted by wegreened on January 9, 2025 in EB1 Green Card, NIW, Technology (Nanotechnology, Nanoscience, Biomaterials, Biomechanics, Biomedical Engineering, Bioinformatics, Bioengineering, Biomedical Science, Biotechnologies)

Client’s Testimonial:

“Amazing, Excellent! Thank you all for your hard work. Also, my experience submitting EB1B applications based on previously successfully filed EB2-NIW was very smooth. I was especially impressed with the promptness of responses. Thank you!”

On August 6^th, 2024 and November 18^th, 2024, we received another EB-2 NIW (National Interest Waiver) and EB-1B (Outstanding Professors and Researchers) Approval for a Senior Application Engineer in the Field of Biotechnology (Approval Notice).

General Field: Biotechnology

Position at the Time of Case Filing: Senior Application Engineer

Country of Origin: South Korea

State of Residence at the Time of Filing: Massachusetts

Approval Notice Date: August 6^th, 2024 (NIW) and November 18^th, 2024 (EB1B)

Processing Time: 29 days (NIW) (Premium Processing Requested) and 6 days (EB1B) (Premium Processing Requested)

Case Summary:

A Senior Application Engineer contacted our law firm to help him establish his significant contributions to the U.S. by filing for an EB-2 NIW (National Interest Waiver) petition. We evaluated our client’s qualifications and research background to certify the precision of his credentials. So, after successfully checking his achievements, we submitted his NIW case to the USCIS.

He even retained our services to construct another petition under the EB-1B (Outstanding Professors and Researchers) visa category. We presented his unique executive background and unprecedented experience important to his current and future work at the USCIS.

Upon reviewing his credentials, we found that:

Our client has completed his Ph.D. in Neuroscience and has an unparalleled documented record of authorship in his field of endeavor.
His work has been published in some of the most prestigious, high-impact journals resulting in 5 peer-reviewed journal articles (1 co-first-authored), 2 preprints (1 of them first-authored), and 3 abstracts (2 of them first-authored).
Moreover, his work has been cited 600 times, according to Google Scholar.
His study has been supported by funding from the NIH, the JPB Foundation, and the NC Cultural Foundation. The NIH, the JPB Foundation, and the NC Cultural Foundation fund projects that promote advancements in public health research and the development of social justice initiatives.

Furthermore, his specialized research has focused on developing high-resolution organ-scale neuroimaging technologies for performing molecular mapping at cellular and sub-cellular resolutions, thereby improving clinical diagnoses, optimizing pharmacological assays, and overall enhancing the robustness of fundamental neuroscience research.

His research addresses some of our nation’s most pressing issues in facilitating the advancement of scalability and efficiency in existing protein labeling techniques, as well as improving immune-labeling efficiency in ultra-high-resolution imaging.

His case was further supported by 4 recommendation letters, out of those one of the recommenders stated:

“It is with distinct pleasure that I write this recommendation in support of [client], a valued voice in the biotechnology community. His contributions to this field do not go unnoticed, and I intend to highlight some of his great accomplishments throughout this letter. [Client] is conducting cutting-edge research into brain architecture and highly prevalent neurological disorders, the high quality of which is clearly shown by his extensive publication record in internationally renowned journals. [Client’s] research in the biotechnology field is undoubtedly of benefit to both the U.S. and global research communities.”

The totality of this evidence, thus shows that our client has been internationally recognized and fully qualified as an outstanding researcher in the field of biotechnology.

Our team’s efforts successfully paid off in conveying to the USCIS that our client’s essential experience in the field of biotechnology has afforded him vast knowledge and formidable skills, which are a significant asset to any research setting and thus set him apart as a vital researcher in his field of expertise today. We would like to congratulate him on securing both the I-140 approvals and thanks to the Premium Processing service upgrade for both NIW and EB1B cases, which were adjudicated in only 29 and 6 days respectively.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%